21
Participants
Start Date
March 31, 2014
Primary Completion Date
April 30, 2016
Study Completion Date
December 21, 2016
Azficel-T (autologous fibroblasts)
"Autologous fibroblasts will be cultured from three 3-mm post auricular punch biopsies. Biopsies will be shipped from the clinical sites to the Fibrocell manufacturing site where the cells will be harvested, tested for sterility, endotoxin level, cell identity, viability and concentration. When the desired cell number is reached, cells will be transported to the investigative site as a suspension in shipping media.~Depending upon the clinical circumstances for each subject, the vocal fold(s) will be injected transorally or percutaneously in order to deposit 1.0 mL of study drug into the lamina propria layer of each vocal fold. The injection process will be visualized via a flexible fiberoptic laryngoscope inserted through the nostril."
Placebo
Subjects randomized to placebo will receive injections of sterile saline into the vocal fold(s).
NYU Langone Medical Center, New York
Surgery/Head and Neck, David Geffen School of Medicine at UCLA, Los Angeles
Dept of Otolaryngology, Stanford Univ Medical Center, Stanford
Lead Sponsor
Castle Creek Biosciences, LLC.
INDUSTRY